Effects of a treatment with coenzyme A, alpha-lipoic acid, diphosphopyridine nucleotide and cocarboxylase on endogenous hepatic coma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000641:Ammonia / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D001797:Blood Protein Electrophoresis; D003065:Coenzyme A / Q000627:therapeutic use*; D004569:Electroencephalography; D004798:Enzymes / Q000097:blood; D005260:Female; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007501:Iron / Q000097:blood; D007773:Lactates / Q000097:blood; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009243:NAD / Q000627:therapeutic use*; D009336:Necrosis; D011773:Pyruvates / Q000378:metabolism; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use*; D008063:Thioctic Acid / Q000627:therapeutic use*
D001779:Blood Coagulation Factors; D004798:Enzymes; D007773:Lactates; D011773:Pyruvates; D009243:NAD; D008063:Thioctic Acid; D000641:Ammonia; D007501:Iron; D013835:Thiamine Pyrophosphate; D001663:Bilirubin; D003065:Coenzyme A